FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to a method for modifying two light chain domains to produce an antibody with enhanced stability, as compared to an antibody not containing said substitutions.
EFFECT: invention allows to obtain antibodies with enhanced stability, as compared to antibodies not containing said substitutions.
22 cl, 4 ex, 14 tbl
Title | Year | Author | Number |
---|---|---|---|
DUAL VARIABLE REGION ANTIBODY-LIKE BINDING PROTEINS HAVING CROSS-OVER BINDING REGION ORIENTATION | 2012 |
|
RU2695880C2 |
POLYSPECIFIC ANTIBODIES CONTAINING ANTIBODY OF FULL LENGTH AND ONE-CHAIN FRAGMENTS FAB | 2010 |
|
RU2598248C2 |
ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2649368C2 |
BISPECIFIC ANTIBODIES SPECIFIC TO PD1 AND TIM3 | 2016 |
|
RU2729371C1 |
MOLECULES WITH CD45 AND CD79 SPECIFICITY | 2015 |
|
RU2747980C2 |
BIOSPECIFIC ANTIGEN-BINDING MOLECULES | 2012 |
|
RU2650775C2 |
MULTISPECIFIC ANTIBODY CONSTRUCTS | 2015 |
|
RU2710730C2 |
POLYPEPTIDES FOR BONDING WITH "RECEPTOR OF ADVANCED GLYCATION ENDPRODUCTS", THEIR COMPOSITIONS AND METHODS, WHICH THEY TAKE PART IN | 2010 |
|
RU2558301C2 |
ANTIBODIES BINDING TO HLA-A2/WT1 | 2018 |
|
RU2815176C2 |
MONOVALENT CARRIER MODULES ACROSS BLOOD-BRAIN BARRIER | 2014 |
|
RU2694659C2 |
Authors
Dates
2018-05-03—Published
2012-10-19—Filed